Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
- PMID: 31450576
- PMCID: PMC6784134
- DOI: 10.3390/antibiotics8030127
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
Abstract
For decades, the performance of antimicrobial stewardship programs (ASPs) has been measured by incidence rates of hospital-onset Clostridioides difficile and other infections due to multidrug-resistant bacteria. However, these represent indirect and nonspecific ASP metrics. They are often confounded by factors beyond an ASP's control, such as changes in diagnostic testing methods or algorithms and the potential of patient-to-patient transmission. Whereas these metrics remain useful for global assessment of healthcare systems, antimicrobial use represents a direct metric that separates the performance of an ASP from other safety and quality teams within an institution. The evolution of electronic medical records and healthcare informatics has made measurements of antimicrobial use a reality. The US Centers for Disease Control and Prevention's initiative for reporting antimicrobial use and standardized antimicrobial administration ratio in hospitals is highly welcomed. Ultimately, ASPs should be evaluated based on what they do best and what they can control, that is, antimicrobial use within their own institution. This narrative review critically appraises existing stewardship metrics and advocates for adopting antimicrobial use as the primary performance measure. It proposes novel formulas to adjust antimicrobial use based on quality of care and microbiological burden at each institution to allow for meaningful inter-network and inter-facility comparisons.
Keywords: Acinetobacter baumannii; Antibiotics; Pseudomonas aeruginosa; antibiotic utilization; broad-spectrum agents; carbapenem-resistant Enterobacteriaceae; extended-spectrum beta-lactamases; hospital epidemiology; infection control; infection prevention; methicillin-resistant Staphylococcus aureus; resistance.
Conflict of interest statement
H.R.W.: Speaker, ALK Abello. P.B.B.: Advisory board member, Melinta Therapeutics; Program content developer and speaker, FreeCE.com; Grant support, ALK Abello. M.N.A.-H. and J.A.J.: No conflicts.
Figures

References
-
- Barlam T.F., Cosgrove S.E., Abbo L.M., MacDougall C., Schuetz A.N., Septimus E.J., Srinivasan A., Dellit T.H., Falck-Ytter Y.T., Fishman N.O., et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin. Infect. Dis. 2016;62:e51–e77. doi: 10.1093/cid/ciw118. - DOI - PMC - PubMed
-
- Moehring R.W., Anderson D.J., Cochran R.L., Hicks L.A., Srinivasan A., Dodds Ashley E.S. Structured Taskforce of Experts Working at Reliable Standards for Stewardship (STEWARDS) Panel. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings. Clin. Infect. Dis. 2017;64:377–383. doi: 10.1093/cid/ciw787. - DOI - PMC - PubMed
-
- Science M., Timberlake K., Morris A., Read S., Le Saux N. Groupe Antibiothérapie en Pédiatrie Canada Alliance for Stewardship of Antimicrobials in Pediatrics (GAP Can ASAP) Pediatrics; Elk Grove, IL, USA: 2019. p. 143. Quality metrics for antimicrobial stewardship programs. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical